Definitive Contract HHSF223201610007C
Award Date 1/26/16
Potential Completion Date 2/28/20
Potential Value $478K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for the preventative maintenance of Illumina's MISEQ BENCHTOP SEQUENCER system. The total ceiling value of the contract is $225,606.45, with a period of performance ending on December 5, 2017. The contract was awarded on November 15, 2016 and did not utilize any set-aside designations. Illumina is a...
- This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $21,183, is for the provision of preventative maintenance services for Illumina's MiSeq benchtop sequencer. The contract does not have a set-aside designation. Illumina has extensive experience providing sequencing systems, reagents, and maintenance services to a variety of...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $237,188.40 and no set-aside designation. Illumina will provide a range of sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and...
- This is a firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for $790,368.08 to provide service and maintenance on MiSeq, NextSeq, and cBot instruments over a period ending on March 23, 2024. The contract does not have a set-aside designation. Illumina is a well-known provider of genomic sequencing systems and related products and...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance and reagents for the company's MiSeq benchtop sequencer. The total ceiling value of the contract is $292,446.20, with a performance period ending on December 5, 2016. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has provided similar products and services to support genomic research and diagnostics for...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- This firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for preventative maintenance on a MiSeq benchtop sequencer, with a potential value of $26,157.45 and a completion date of September 29, 2018. Illumina has a history of providing sequencing systems and related products and services to support genomic research and diagnostics at...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The $184,226.00 contract has an ultimate completion date of December 5, 2016. Illumina is a for-profit manufacturer and provider of genomic sequencing and analysis solutions. Through prior federal contracts, Illumina has supplied a range of sequencing systems, reagents, and related services to...